Lucía Cabal-Hierro
Lucía Cabal-Hierro
C4Therapeutics
Dirección de correo verificada de c4therapeutics.com
Título
Citado por
Citado por
Año
Signal transduction by tumor necrosis factor receptors
L Cabal-Hierro, PS Lazo
Cellular signalling 24 (6), 1297-1305, 2012
4712012
Blastic plasmacytoid dendritic cell neoplasm is dependent on BCL2 and sensitive to venetoclax
J Montero, J Stephansky, T Cai, GK Griffin, L Cabal-Hierro, K Togami, ...
Cancer discovery 7 (2), 156-164, 2017
1062017
NF-κB signal triggering and termination by tumor necrosis factor receptor 2
M Rodríguez, L Cabal-Hierro, MT Carcedo, JM Iglesias, N Artime, ...
Journal of Biological Chemistry 286 (26), 22814-22824, 2011
592011
TRAF-mediated modulation of NF-kB AND JNK activation by TNFR2
L Cabal-Hierro, M Rodríguez, N Artime, J Iglesias, L Ugarte, MA Prado, ...
Cellular signalling 26 (12), 2658-2666, 2014
552014
A TRAF2 binding independent region of TNFR2 is responsibl for TRAF2 depletion and enhancement of cytotoxicity driven b TNFR1
L Cabal-Hierro, A Noelia, J Iglesias
Oncotarget 5 (1), 224, 2014
282014
Trisomy of a Down syndrome critical region globally amplifies transcription via HMGN1 overexpression
CT Mowery, JM Reyes, L Cabal-Hierro, KJ Higby, KL Karlin, JH Wang, ...
Cell reports 25 (7), 1898-1911. e5, 2018
202018
Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents
ODPJ Vasilevskaya IA, Selvakumaran M, Hierro LC, Goldstein SR, Winkler JD
Clinical Cancer Research 21 (18), 4143-52, 2015
132015
TNF signaling through RIP1 kinase enhances SN38-induced death in colon adenocarcinoma
L Cabal-Hierro, PJ O'Dwyer
Molecular Cancer Research 15 (4), 395-404, 2017
102017
Microtubule interfering agents and KSP inhibitors induce the phosphorylation of the nuclear protein p54nrb, an event linked to G2/M arrest
P Casado, MA Prado, P Zuazua-Villar, E Del Valle, N Artime, ...
Journal of proteomics 71 (6), 592-600, 2009
102009
Chromatin accessibility promotes hematopoietic and leukemia stem cell activity
L Cabal-Hierro, P van Galen, MA Prado, KJ Higby, K Togami, CT Mowery, ...
Nature communications 11 (1), 1-18, 2020
92020
Proteomic analysis of annexin A2 phosphorylation induced by microtubule interfering agents and kinesin spindle protein inhibitors
B Fernandez-Garcia, P Casado, MA Prado, LJ Ugarte-Gil, N Artime, ...
Journal of proteome research 9 (9), 4649-4660, 2010
62010
Blastic plasmacytoid dendritic cell neoplasm is dependent on BCL2 and sensitive to venetoclax. Cancer Discov. 2017; 7: 156–164. doi: 10.1158/2159-8290
J Montero, J Stephansky, T Cai, GK Griffin, L Cabal-Hierro, K Togami, ...
CD-16-0999.[PMC free article][PubMed][CrossRef][Google Scholar], 0
6
Phosphorylation of human eukaryotic elongation factor 1Bγ is regulated by paclitaxel
MA Prado, P Casado, P Zuazua‐Villar, E del Valle, N Artime, ...
Proteomics 7 (18), 3299-3304, 2007
52007
Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis
K Togami, SS Chung, V Madan, L Cabal-Hierro, J Taylor, SS Kim, ...
bioRxiv, 2020
12020
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Is Highly BCL-2 Dependent and Sensitive to Venetoclax
J Montero, J Stephansky, T Cai, GK Griffin, K Togami, L Cabal-Hierro, ...
Blood, The Journal of the American Society of Hematology 128 (22), 4045-4045, 2016
12016
Male-Biased Spliceosome Mutations in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Impair pDC Activation and Apoptosis
K Togami, SS Chung, V Madan, CM Kenyon, L Cabal-Hierro, J Taylor, ...
BLOOD 136, 2020
2020
Nucleosome Binding Protein HMGN1 Promotes HSPC Competitive Advantage with Decreased Quiescence and Cooperates with AML Oncogenes to Block Differentiation and Increase Clonogenicity
L Cabal-Hierro, K Togami, K Higby, AA Lane
Blood 132 (Supplement 1), 2606-2606, 2018
2018
NUCLEOSOME BINDING PROTEIN HMGN1 BLOCKS MYELOIDDIFFERENTIATION AND PROMOTES CLONAL DOMINANCE VIA ABERRANT HISTONE ACETYLATION
L Cabal-Hierro, P Van Galen, M Prado, K Togami, C Mowery, K Higby, ...
HAEMATOLOGICA 102, 153-154, 2017
2017
Potentiation of oxaliplatin in colon cancer by JNK inhibition
I Vasilevskaya, M Selvakumaran, L Cabal-Hierro, P O’Dwyer
European Journal of Cancer 50, 154-155, 2014
2014
Inhibition of JNK signaling sensitizes hypoxic colon cancer cells to DNA-damaging agents
IA Vasilevskaya, M Selvakumaran, L Cabal-Hierro, PJ O'Dwyer
Cancer Research 74 (19 Supplement), 488-488, 2014
2014
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20